Skip to Content

Clinical Trial Detail

GOG 0212

Patient Information

A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT 2103 (IND# 70177) Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancer who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy

Study Number
GOG 0212

Clinical Trial Categories

  • Ovarian Cancer

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725

Directions

Large Conference Room: Please enter the building through the door to the right of the main entrance…this door is a direct entrance to our meeting room. The Valet service is operating at our main entrance for our patients.

Also in this Section